A simulation-based analysis for effective distribution of COVID-19 vaccines: A case study in Norway
Since December 2020, the vaccines from several manufacturers, e.g., Pfizer/BioNTech, Moderna, etc., have been approved for mass vaccination to control the COVID-19 pandemic, which has caused more than 100 million infections and 2.4 million deaths. These vaccines are produced and transported in large...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-09-01
|
| Series: | Transportation Research Interdisciplinary Perspectives |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590198221001585 |